Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients

Clinical trial NCT07663253 · RECRUITING

Trial details

NCT number: NCT07663253
Sponsor: Shanghai Zhongshan Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2026-06-01
Primary completion: 2027-02-01
Enrollment: 333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.